Earnings History Data for Timber Pharmaceuticals, Inc. (TMBR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Timber Pharmaceuticals, Inc.

Timber Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on the development and commercialization of treatments for orphan dermatologic diseases. The Company is initially engaged on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis, tuberous sclerosis complex and localized scleroderma. Timber Pharmaceuticals Inc., formerly known as BioPharmX Corporation, is based in NJ, United States.

Release Date	Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
21-08-2023	AH	TMBR	Timber Pharmaceuticals	5.00	-1.27	-0.79	0.00		3.01	0.02 (0.67%)	2.86	-0.13 (-4.35%)	1.20 - 8.73	767,396	1,990,000	38,554
Timber to be taken private by LEO Pharma, stock soars 100% [8/21/2023 12:10 PM] Timber Pharmaceuticals to be acquired by Denmark-based LEO Pharma [8/21/2023 11:49 AM]
15-05-2023	AH	TMBR	Timber Pharmaceuticals	5.00	-1.32	-1.17	0.00	Timber Pharmaceuticals GAAP EPS of -$1.32 [5/15/2023 5:02 PM]	1.48	-0.13 (-8.07%)	1.55	-0.06 (-3.73%)	1.20 - 20.50	24,858	20,000	404
Timber Pharmaceuticals GAAP EPS of -$1.32 [5/15/2023 5:02 PM]
14-11-2022	PM	TMBR	Timber Pharmaceuticals	5.00	-1.52	-2.00	0.00	Timber Pharmaceuticals GAAP EPS of -$1.52 [11/14/2022 8:50 AM]	1.85	-0.01 (-0.54%)	1.93	0.07 (3.76%)	1.40 - 31.00	218,574	120,000	15,749
Timber Pharmaceuticals GAAP EPS of -$1.52 [11/14/2022 8:50 AM] Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2022 Financial Results [Nov-14-22 08:00AM]
11-08-2022	AH	TMBR	Timber Pharmaceuticals	7.00	-0.09	-0.04	0.00	Timber Pharmaceuticals GAAP EPS of -$0.15 misses by $0.11 [8/11/2022 5:28 PM]	0.1350	-0.02 (-10.00%)	0.14	-0.01 (-8.80%)	0.09 - 1.12	40,074,321	46,320,000	5,077,832
Timber Pharmaceuticals GAAP EPS of -$0.15 misses by $0.11 [8/11/2022 5:28 PM] Timber Pharmaceuticals Provides Business Update and Announces Second Quarter 2022 Financial Results [Aug-11-22 05:20PM]
12-05-2022	AH	TMBR	Timber Pharmaceuticals	18.00	-0.05	-0.04	0.00	Timber Pharmaceuticals GAAP EPS of -$0.05 [5/12/2022 4:49 PM]	0.2532	0.01 (2.39%)	0.26	0.01 (5.14%)	0.23 - 1.41	191,782	1,150,000	4,242
Timber Pharmaceuticals GAAP EPS of -$0.05 [5/12/2022 4:49 PM] Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2022 Financial Results [May-12-22 04:10PM]